tigecycline (Tygacil) for community-acquired pneumonia (CAP)

May 2009

Reps will be promoting tigecycline (Tygacil) for community-acquired pneumonia (CAP).

It's now approved for this use in hospitalized patients who aren't in the ICU...but it's usually not the best choice.

The usual empiric therapy for these patients is monotherapy with levofloxacin or moxifloxacin...or a combination of a beta-lactam plus macrolide.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote